Cover Image
QR Code

Pharmacogenomics in cancer therapy.

Pharmacogenomics is the study of how genetic variations affect drug response. These variations can influence a patient's response to chemotherapy. To date, several specific drug-gene pairs have been described that can help guide individualized cancer treatment.

Published in:Canadian Journal of Pathology Vol. 15; no. 1; pp. 7 - 13
Main Author: Di Meo, Ashley
Format: Journal Article
Published: Canadian Association of Pathologists Mar2023
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=162524978&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 162524978
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1918915X
        B17Q
      jtl: Canadian Journal of Pathology
      issn: 1918915X
      maglogo: N
    pubinfo:
      dt: Mar2023
      vid: 15
      iid: 1
      pid: 62888
      pub: Canadian Association of Pathologists
      place: Kingston, Ontario
    artinfo:
      ui:
        162524978
        162524978
      ppf: 7
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Pharmacogenomics in cancer therapy.
      aug:
        au: Di Meo, Ashley
        affil: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
      sug:
        subj:
          Neoplasms Drug Therapy
          Chemotherapy, Cancer
          Pharmacogenetics
          Neoplasms Familial and Genetic
          Genetic Variation
          Drug Interactions
          Individualized Medicine
          Oncologic Care
      ab:
        Pharmacogenomics is the study of how genetic variations affect drug response. These variations can influence a patient's response to chemotherapy. To date, several specific drug-gene pairs have been described that can help guide individualized cancer treatment.
        La pharmacogénomique a pour objet l'étude des effets des variations génétiques sur la réponse aux médicaments. Ces variations peuvent influer sur la réponse d'un·e patient·e à la chimiothérapie. À ce jour, plusieurs paires gène-médicament précises ont été décrites et peuvent aider à individualiser le traitement du cancer.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N